PanaceaNano, Inc.
USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Panaceanano ranks #49,471 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 11 technology areas.
- #49,471
- of 49,997 US assignees by volume
- 40th percentile
- by Innovation Score (32.0/100)
- 23.4
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R49471 · US Corporation #49,471 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #49,471/49,997
- PHOTO-FINISH Palliare
- CPC-FOCUS A61K · 11 areas
- INNOV-THIN 32.0/100
- CLAIMS-DENSE 23.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Palliare Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Panaceanano’s 32.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Panaceanano
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- PanaceaNano · this assignee 32
PanaceaNano · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Panaceanano's Innovation Score is 32.0/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Panaceanano?
Each dot is one of Panaceanano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Panaceanano’s own 23.4 claims/patent is ABOVE the 19.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Panaceanano's grants concentrate
PanaceaNano, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 60% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (3 grants) versus a trough of 2 in 2020. By volume, Panaceanano sits between Palliare Limited and Paptic Oy.
Who files at PanaceaNano's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Palliare
Palliare Limited
5 patents
- Palm Silage
Palm Silage, Inc.
5 patents
- Panoptica
PanOptica, Inc.
5 patents
- Panacea Biomatx
Panacea Biomatx, Inc.
5 patents
- Pandemic Insights
Pandemic Insights, Inc.
5 patents
- Panji
Panji, LLC
5 patents
- Paofit Holdings P…
Paofit Holdings Pte Ltd.
5 patents
- Paptic Oy
Paptic Oy
5 patents
- Panaceanano ◀
PanaceaNano, Inc.
5 patents
What this shows PanaceaNano holds 5 patents at rank #49,659, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near PanaceaNano
By rank, the assignees closest to #49,659 in granted patent volume.
- Palliare Limited #49,655 · 5 patents
- Palm Silage, Inc. #49,656 · 5 patents
- PanOptica, Inc. #49,657 · 5 patents
- Panacea Biomatx, Inc. #49,658 · 5 patents
- Pandemic Insights, Inc. #49,660 · 5 patents
- Panji, LLC #49,661 · 5 patents
- Paofit Holdings Pte Ltd. #49,662 · 5 patents
- Paptic Oy #49,663 · 5 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in PanaceaNano's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Panaceanano's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 40th percentile higher than 40% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 60.0% |
| 2020 | 2 | 40.0% |
Which technologies does PanaceaNano, Inc. patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
PanaceaNano, Inc.'s patent record in context - here's where to go next.
- PanaceaNano, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 60% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #49,471 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare PanaceaNano, Inc. against Palliare Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.